In summary, differences in SETD7 mRNA or protein levels in BC cell lines vs. non-malignant cell lines may relate to methodological bias (i.e., antibody specificity, confluency, time in culture before sample processing, effect of transfection reagents on basal cellular stress as shown previously [47] and also observed by us (unpublished)). The gene discussed is SETD7; the disease is breast cancer.